BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15124379)

  • 1. Racial disparities in prescription drug use among dually eligible beneficiaries.
    Schore J; Brown R; Lavin B
    Health Care Financ Rev; 2003; 25(2):77-90. PubMed ID: 15124379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare Part D: successes and continuing challenges. Impact of Medicare Part D on Massachusetts health programs and beneficiaries.
    Thomas CP; Sussman J; ;
    Issue Brief (Mass Health Policy Forum); 2007 May; (32):1-32. PubMed ID: 17546802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial and ethnic disparities in prescription coverage and medication use.
    Briesacher B; Limcangco R; Gaskin D
    Health Care Financ Rev; 2003; 25(2):63-76. PubMed ID: 15124378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription drugs: recent trends in utilization, expenditures, and coverage.
    Sethi RC
    EBRI Issue Brief; 2004 Jan; (265):1-35. PubMed ID: 14969223
    [No Abstract]   [Full Text] [Related]  

  • 5. Medicare program; Medicare prescription drug discount card. Interim final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Dec; 68(240):69839-927. PubMed ID: 14674398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.
    Donohue JM; Frank RG
    Psychiatr Serv; 2007 Oct; 58(10):1285-91. PubMed ID: 17914004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State payment limitations on Medicare cost-sharing: impact on dually eligible beneficiaries.
    Mitchell JB; Haber SG
    Inquiry; 2004-2005 Winter; 41(4):391-400. PubMed ID: 15835598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and ethnic disparities in benefits eligibility and spending among adults on the autism spectrum: A cohort study using the Medicare Medicaid Linked Enrollees Analytic Data Source.
    Benevides TW; Carretta HJ; Rust G; Shea L
    PLoS One; 2021; 16(5):e0251353. PubMed ID: 34032811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dually eligible individuals with AIDS: characteristics and health services use.
    Sambamoorthi U; Collins S; Crystal S
    J Health Soc Policy; 2001; 14(1):19-35. PubMed ID: 11374296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The implications of the Medicare Modernization Act for dual eligibles.
    Deshpande M
    Am J Geriatr Cardiol; 2005; 14(6):298-300. PubMed ID: 16276126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons for Medicare Part D in the hemodialysis community.
    Nayeem AI; Chertow GM
    BMC Nephrol; 2006 Jul; 7():11. PubMed ID: 16824211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care utilization among Medicare-Medicaid dual eligibles: a count data analysis.
    Moon S; Shin J
    BMC Public Health; 2006 Apr; 6():88. PubMed ID: 16595021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transition to Medicare Part D: an early snapshot of barriers experienced by younger dual eligibles with disabilities.
    Hall JP; Kurth NK; Moore JM
    Am J Manag Care; 2007 Jan; 13(1):14-8. PubMed ID: 17227199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What does the Medicare prescription drug legislation mean for the American cardiologist?
    Schwartz JB; Redberg RF
    Am J Geriatr Cardiol; 2005; 14(6):317-24. PubMed ID: 16276130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare Part D: selected issues for pharmacists and beneficiaries in 2007.
    Kilian J; Stubbings J
    J Manag Care Pharm; 2007; 13(1):59-65. PubMed ID: 17269838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to Care for Medicare-Medicaid Dually Eligible Beneficiaries: The Role of State Medicaid Payment Policies.
    Zheng NT; Haber S; Hoover S; Feng Z
    Health Serv Res; 2017 Dec; 52(6):2219-2236. PubMed ID: 27767203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modeling the potential impact of a prescription drug copayment increase on the adult asthmatic medicaid population.
    Bae SJ; Paltiel AD; Fuhlbrigge AL; Weiss ST; Kuntz KM
    Value Health; 2008; 11(1):110-8. PubMed ID: 18237365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.